Liquid Filtration for Pharmaceutical Market Competitive and Value Chain Analysis Insight

According to Towards
Healthcare data, the global liquid
filtration for pharmaceuticals market is
growing quickly and is expected to generate hundreds of millions in revenue
between 2025 and 2034. This growth is being driven by rising investments,
continuous innovation, and increasing demand from multiple industries.

Several factors contribute to
market growth, including the increasing development of biologics and targeted therapy, and advancements in manufacturing
technologies. The demand for personalized medicines is increasing due to a rise
in chronic disorders and the geriatric population. Government bodies provide funding
for installing advanced manufacturing technologies for pharmaceutical and biotechnology products.

The Complete Study
is Now Available for Immediate Access | Download the Sample Pages of this
Report @ https://www.towardshealthcare.com/download-sample/5934

The Liquid Filtration for Pharmaceutical
Market: Highlights

➢ North America dominated the global market share by 40% in
2024.

➢ Asia-Pacific is expected to witness the fastest growth
during the predicted timeframe.

➢ By type of filtration technology, the membrane filtration
segment held a dominant revenue share of the market in 2024.

➢ By type of filtration technology, the ultrafiltration
sub-segment is expected to grow at the fastest CAGR in the market during the
forecast period.

➢ By filter media type, the polyethersulfone (PES) segment
accounted for the highest revenue share of the market in 2024.

➢ By filter media type, the polyvinylidene fluoride (PVDF)
segment is expected to witness the fastest growth in the liquid filtration for
pharmaceutical market over the forecast period.

➢ By application, the sterile filtration segment held a major
revenue share of the market in 2024.

➢ By application, the clarification filtration segment is
expected to expand rapidly.

➢ By end-user, the pharmaceutical manufacturers segment led
the market in 2024.

➢ By end-user, the contract manufacturing organizations
(CMOs) segment is expected to show the fastest growth in the upcoming years.

➢ By filtration equipment type, the filter cartridges segment
contributed the biggest revenue share of the market in 2024.

➢ By filtration equipment type, the filter capsules segment
is expected to grow with the highest CAGR in the market during the studied
years.

What is Liquid Filtration for
Pharmaceuticals?

The liquid filtration for
pharmaceutical market refers to the development and distribution of special
filters to remove impurities from pharmaceutical products during manufacturing.
Filters eliminate contaminants, such as bacteria, viruses, dust, dirt, and
other debris, to improve product quality. The various types of filters used in
the pharmaceutical industry include membrane, depth, cartridge, bag, and
activated carbon. The selection of the filters depends on the type of
pharmaceutical to be manufactured.

You can place an
order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Advanced Membrane Technologies:
Major Potential

Advancements in membrane
technologies have emerged as a major potential in developing innovative filters
with greater efficacy and reduced complexity. Nanofiltration and membrane
filtration provide superior filtration efficiency as they are semi-permeable
filters with extremely fine pores. They offer numerous benefits, such as
increased durability, fouling resistance, and higher permeability.
Additionally, scientists develop novel filter materials like polyethersulfone
(PES) and polyvinylidene fluoride (PVDF) to optimize the filtration process.

High Cost: Major Limitation

The installation and maintenance
of filter materials for liquid filtration, especially at large-scale
operations, are highly expensive. Innovative filter materials are more costly
than conventional filter materials. This limits the affordability of numerous
pharmaceutical and biotech companies from low- and middle-income countries, restricting market growth.

The Liquid Filtration for
Pharmaceutical Market: Regional Analysis

North America held a major revenue
share of the market by 40% in 2024. The market in North America is driven by
the strong presence of leading pharmaceutical and biotech companies and a
robust healthcare infrastructure. Government organizations provide funding for
installing advanced filter systems. Favorable regulatory policies and
increasing collaborations among key players propel market growth. Furthermore,
the demand for personalized medicines and the increasing number of contract development and
manufacturing organizations (CDMOs) foster the market.

The U.S. is home to over 5,000
pharmaceutical companies and 3,000 biotechnology companies that deliver
high-quality products. Key players, such as Eli Lilly and Company, Pfizer,
Inc., and AbbVie, Inc., are major contributors to the pharmaceutical sector in
the U.S. The filtration system should comply with the Food and Drug
Administration (FDA) and the United States Pharmacopoeia (USP) guidelines.

The Canadian pharmaceutical sector
ranks sixth globally, with a 2.1% share of the global market. This is due to increasing
manufacturing activities, burgeoning drug sales, and expanding trade policies
with foreign nations. In 2023, the total drug sales in Canada were $42.1
billion, including patented and non-patented drugs.

Asia-Pacific is expected to
grow at the fastest CAGR in the market during the forecast period.

The liquid filtration for
pharmaceutical market is experiencing significant expansion, with the
burgeoning pharmaceutical and biotech sector and favorable government support.
Asia-Pacific countries like China, India, and Japan have suitable manufacturing
infrastructure, encouraging foreign players to set up their manufacturing
facilities in these countries. The increasing number of pharmaceutical and
biotech startups and venture capital investments contributes to market growth.

China boasts more than 10,000
pharmaceutical companies. According to the latest J.P. Morgan report, 27% of
the total global big pharma deals with over $50 million originated from China
in 2024. Additionally, around 39% of the total global big pharma funding of
over $50 million was paid to Chinese firms in 2024.

Download the single region market report
@ https://www.towardshealthcare.com/price/5934

The Liquid Filtration for
Pharmaceutical Market: Segmentation Analysis

By Type of Filtration
Technology

The membrane filtration segment
dominated the market in 2024. This segment dominated because membrane filters
have a lower chance of clogging during sterile filtration. Membrane filters are
plastic semi-permeable membranes that separate products using a driving force.
Different types of membrane filtration techniques include ultrafiltration,
nanofiltration, reverse osmosis, and microfiltration. They offer numerous
benefits, including prolonged filtration and high speed.

The ultrafiltration sub-segment is
expected to expand rapidly. The membrane filtration technologies are
categorized based on the pore size of the filters. Ultrafilters have a pore
size of 0.002 to 0.1. They are primarily used to filter microorganisms, humic
materials, and some viruses from pharmaceuticals. The demand for
ultrafiltration is increasing as it does not require pH adjustments or
disinfection.

By Filter Media Type

The polyethersulfone (PES) segment
held the largest revenue share of the liquid filtration for pharmaceutical
market in 2024. This is due to the hydrophilic and low protein-binding ability
of PES. PES membrane filters are commonly used for tissue culture media
sterilization and other life science applications. They are comparatively cost-effective and have a high
retention factor. The hydrophilic nature of the filter allows the media to
provide lower pressure loss, ultimately increasing its shelf-life.

The polyvinylidene fluoride (PVDF)
segment is expected to grow at the fastest CAGR in the market during the
forecast period. PVDF is widely used for filtering gases or ventilation without
moisture blockage. PVDF membrane filters can be either hydrophilic or
hydrophobic, with high chemical compatibility and no protein adsorption. They
are installed to achieve the highest requirements without the need for wetting
agents.

Get the latest insights on life science
industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

By Application

The sterile filtration segment
held a dominant presence in the liquid filtration for pharmaceutical market in
2024. This is due to the need for highly pure and contamination-free
pharmaceutical products. Products contaminated with microorganisms may cause
serious health problems in patients. Thus, regulatory agencies impose stringent
regulations on the presence of microorganisms in pharmaceuticals. The main
objective of sterile filtration is to maintain product integrity.

The clarification filtration
segment is expected to grow with the highest CAGR in the market during the
studied years. Clarification filtration is a type of prefiltration step to
remove visual impurities that can affect product quality. Prefilters remove the
majority of contaminants from the product and enhance the shelf-life of the
main filters by imposing less load on final filtration. This ultimately saves
the cost of manufacturers.

By End-User

The pharmaceutical manufacturers
segment contributed the biggest revenue share of the liquid filtration for
pharmaceutical market in 2024. Pharmaceutical companies have a favorable
manufacturing infrastructure to conduct in-house manufacturing of
pharmaceuticals. They have suitable capital investment to install advanced
filtration systems. They continuously expand their biopharmaceutical area to
focus on the manufacturing of biologics and other complex therapeutics.

The contract manufacturing
organizations (CMOs) segment is expected to witness the fastest growth in the
market over the forecast period. Large pharmaceutical companies outsource their
manufacturing capabilities to CMOs to focus on their core competencies, such as
product sales and marketing. Small- and medium-sized enterprises collaborate
with CMOs as they lack specialized manufacturing infrastructure.

By Filtration Equipment Type

The filter cartridges segment
accounted for the highest revenue share of the liquid filtration for
pharmaceutical market in 2024. Filter cartridges are tube-like, structured
filtration devices that are used to trap solid debris suspended in a liquid.
Cartridge filters are designed from a variety of metallic and non-metallic
materials. Some common examples include cellulose, polypropylene, activated
carbon, and ceramic. They are used in the pharmaceutical industry to maintain
sterility and purity in the manufacturing of pharmaceuticals.

The filter capsules segment is
expected to show the fastest growth in the upcoming years. Filter capsules are
primarily used for small-scale applications and in places with space
constraints. Laboratories use them for venting and gas filtration of biopharmaceutical
processes. Filter capsules are easier to use as they are self-contained, and
the installation is straightforward and quick.

Become a valued research partner with us
– https://www.towardshealthcare.com/schedule-meeting

Top Companies and Their Contributions
to the Market

Companies

Contributions & Offerings

Avantor Sciences

Avantor offers a wide range of filtration solutions, from
filters to custom, complex filter assemblies for sterility and bioburden
reduction.

Brother Filtration

Brother Filtration is a leading manufacturer of
high-quality filtration products for diverse applications, including
biopharmaceuticals.

Parker Hannifin Corporation

Parker offers filtration solutions for complex
contaminant management issues through its Industrial Process Filtration
Division.

Koch Membrane Systems, Inc.

Koch Membrane Systems develops and manufactures spiral,
tubular, and hollow-fiber membranes.

Liquid Filtration for
Pharmaceutical Market Top Companies

• Avantor Sciences

• Brother Filtration

• Parker Hannifin Corporation

• Koch Membrane Systems, Inc.

• Pall Corporation

• Sartorius AG

• Merck KGaA

• 3M Company

• Atlas Filtri

• Pentair plc

• Dow Water & Process Solutions

Recent Developments in the
Liquid Filtration for Pharmaceutical Market

➢ In June 2025, Cytiva Life Sciences announced the completion
of its expansion projects in the U.S., Europe, and Asia through an investment
of $1.6 billion. The expansion is part of Cytiva’s long-term growth plan and
in-region manufacturing strategy.

➢ In December 2024, Ahlstrom announced the acquisition of
ErtelAlsop to strengthen its position in the life science filtration market,
allowing the company to enter the depth filtration space. ErtelAlsop will
become part of Ahlstrom’s Filtration and Life Sciences business.

➢ In June 2024, Asahi Kasei announced the launch of a
membrane system, MicrozaTM hollow-fiber membrane, to produce water for
injection (WFI). The system was developed as an alternative to conventional
distillation processes for the production of WFI for water treatment and
filtration of liquid products.

Download the Competitive Landscape market
report @ https://www.towardshealthcare.com/price/5934

Liquid Filtration for
Pharmaceutical Market Segmentation

By Type of Filtration
Technology

• Membrane Filtration

○
Microfiltration

○
Ultrafiltration

○
Nanofiltration

○
Reverse Osmosis

• Depth Filtration

○
Cellulose-based Depth Filters

○
Synthetic Depth Filters

• Pre-filtration/Coarse Filtration

• Crossflow Filtration

• Others

○
Gravity Filtration

○
Screen Filtration

By Filter Media Type

• Polyethersulfone (PES) 

• Polyvinylidene Fluoride (PVDF)

• Nylon

• Polytetrafluoroethylene (PTFE)

• Cellulose Acetate (CA)

• Polypropylene (PP)

• Others

By Application

• Sterile Filtration

• Clarification Filtration

• Bioburden Reduction

• Solvent Filtration

• Cell Culture Filtration

• Others

By End-User

• Pharmaceutical Manufacturers

• Contract Manufacturing Organizations (CMOs)

• Biopharmaceutical Companies

• Research & Development Institutes

• Others

By Filtration Equipment Type

• Filter Cartridges

• Filter Capsules

• Filter Plates & Frames

• Filter Housings

• Filter Bags

• Others

By Region

• North America

○
U.S.

○
Canada

• Asia Pacific

○
China

○
Japan

○
India

○
South Korea

○
Thailand

• Europe

○
Germany

○
UK

○
France

○
Italy

○
Spain

○
Sweden

○
Denmark

○
Norway

• Latin America

○
Brazil

○
Mexico

○
Argentina

• Middle East and Africa (MEA)

○
South Africa

○
UAE

○
Saudi Arabia

○
Kuwait

Immediate Delivery
Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5934

Access our exclusive,
data-rich dashboard dedicated to the healthcare market – built specifically for
decision-makers, strategists, and industry leaders. The dashboard features
comprehensive statistical data, segment-wise market breakdowns, regional
performance shares, detailed company profiles, annual updates, and much more.
From market sizing to competitive intelligence, this powerful tool is one-stop
solution to your gateway.

Access the
Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Towards Healthcare is a leading global provider of technological
solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life
sciences sector, we build strategic partnerships that generate actionable
insights and transformative breakthroughs. As a global strategy consulting
firm, we empower life science leaders to gain a competitive edge, drive
research excellence, and accelerate sustainable growth.

You can place an
order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region: +44 778 256 0738

North America
Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Find us on social
platforms: LinkedIn | Twitter | Instagram
| Medium | Pinterest

Browse More of Towards Healthcare:

Gene Editing at
Bristol Myers Squibb: https://www.towardshealthcare.com/companies/gene-editing-bristol-myers-squibb-companies

Stryker &
Siemens Healthineers with Robotic Stroke Solutions: https://www.towardshealthcare.com/companies/stryker-siemens-neurovascular-robotics

Top Global Players
in the Life Sciences Market in 2025: https://www.towardshealthcare.com/companies/key-players-in-the-life-sciences-market

Top Companies Innovating
in GLP-1 Obesity Treatments in 2025: https://www.towardshealthcare.com/companies/top-companies-innovating-in-glp-1-obesity-treatments

RaySearch &
Radiology Oncology Systems to Expand Cancer Care: https://www.towardshealthcare.com/companies/raysearch-radiology-oncology-systems-partnership-companies